mGluR3 PAM/NAM (Addex Therapeutics/Pierre Fabre)

N/A

Report date: 2025/03/20 15:50:41
NME

Base Information

Drug NamemGluR3 PAM/NAM (Addex Therapeutics/Pierre Fabre)
Drug Alias NamemGluR3 PAM (Addex Therapeutics/Pierre Fabre)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabotropic glutamate receptor 3 modulators
TargetsMetabotropic glutamate receptor 3
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAddex Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAddex Therapeutics LtdPierre Fabre Ltd
Inactive CompaniesN/A
Active IndicationsNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A